Our Portfolio

With a focus on late pre-clinical to clinical stage ventures and covering a diversified range of therapeutic areas, we partner with the most ambitious scientists and entrepreneurs to build companies around game-changing life science innovation.

Mesh

Investors

Public market access to revolutionary medical innovation.

Find the latest share price, presentations, events and regulatory announcements here.

Share price